IP Library › Granted Patent US 10,222,388
Granted Patent B2
US 10,222,388 · App. 14/910,881 · Granted Mar 5, 2019

25-OH vitamin D derivatives for determining vitamin D metabolites

Inventors: Vukic Soskic (Mainz, DE); Robert Poppe (Mainz, DE)
Assignee: ORGENTEC DIAGNOSTIKA GMBH
G01N33/82C07C401/00C07D495/04C07C2601/14C07C2602/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,222,388
App. No.
14/910,881
Granted
Mar 5, 2019
Kind
B2
Abstract

The present invention relates to new vitamin D compounds which are bonded to a labelling group at the C3 stereocentre by means of a linker. The present invention further relates to a method for producing these vitamin D compounds and to the use of an intermediate for producing these compounds. The present invention also relates to a method for quantitatively determining vitamin D using a vitamin D compound according to the invention as a tracer. Furthermore, the present invention relates to a reagent for determining vitamin D, containing a compound according to the invention, and to the use thereof for determining vitamin D.

Claims (4)

1. A compound having a structure according to formula (Ib)

or formula (Ic)

2. A compound according to claim 1 , having a structure according to formula (Ib)

3. A compound according to claim 1 , having a structure according to formula (Ic)

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2016
From: SOSKIC, VUKIC; POPPE, ROBERT
To: ORGENTEC DIAGNOSTIKA GMBH
Reel/Frame 037692/0015 →
Priority Claims (1)
DE 10 2013 215 580 · Aug 7, 2013 · national
Continuity (2)
Related Publication 20160195556A1 · Jul 7, 2016
Related Publication 20170115313A9 · Apr 27, 2017
Cited By (1)
US 12,233,115